The global CAR T Cell Therapy market is estimated to be valued at USD 2.26 billion in 2022 and is expected to exhibit a CAGR of 20.9% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
CAR T Cell Therapy is a type of immunotherapy that uses a patient's own genetically modified T cells to target and destroy...